{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:13:34Z","timestamp":1768526014131,"version":"3.49.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Some families affected by von Willebrand disease type 1 show high penetrance with exceptionally low von Willebrand factor (VWF) levels. Previously, a mutation associated with this dominant phenotype, Cys1149Arg, was found to decrease the secretion of coexpressed normal VWF, and the mutation was proposed to cause intracellular retention of pro-VWF heterodimers. To demonstrate heterodimer formation, a model was developed in which subunits could be distinguished immunologically and by size. Recombinant VWF lacking domain A1 (dA1), A3 (dA3), or both (dA13) was secreted efficiently as a full range of multimers. Cotransfection of Cys1149Arg and dA13 resulted in the secretion of multimeric VWF containing about 250 kd (Cys1149Arg) and about 210 kd (dA13). Cell lysates contained pro-VWF forms of Cys1149Arg and dA13. Immunoprecipitation with an antidomain A1 antibody recovered both subunits in heterodimers, and subunit ratios were consistent with random dimerization. Similar results were obtained for cotransfection of Cys1149Arg and dA1. Normal VWF has a Cys1149-Cys1169 intrachain bond. When cotransfected with normal VWF, Cys1149Arg or the double mutant Cys1149Arg+Cys1169Ser caused a similar decrease in VWF secretion, suggesting that an unpaired Cys1169 does not explain the intracellular retention of Cys1149Arg. VWF Cys1149Arg was not secreted from BHK cells but was degraded intracellularly within about 4 hours, and the proteasome inhibitor lactacystin delayed its clearance more than 16 hours. Thus, dominant von Willebrand disease type 1 may be caused by heterodimerization of mutant and normal subunits in the endoplasmic reticulum followed by proteasomal degradation in the cytoplasm. A similar dominant negative mechanism could cause quantitative deficiencies of other multisubunit proteins.<\/jats:p>","DOI":"10.1182\/blood.v98.10.2973","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"2973-2979","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins"],"prefix":"10.1182","volume":"98","author":[{"given":"Imre","family":"Bodo\u0301","sequence":"first","affiliation":[{"name":"From the Howard Hughes Medical Institute and the Departments of Medicine, Biochemistry, and Molecular Biophysics, Washington University School of Medicine, St Louis, MO; and the Department of Hematology, Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Katsumi","sequence":"additional","affiliation":[{"name":"From the Howard Hughes Medical Institute and the Departments of Medicine, Biochemistry, and Molecular Biophysics, Washington University School of Medicine, St Louis, MO; and the Department of Hematology, Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodee A.","family":"Tuley","sequence":"additional","affiliation":[{"name":"From the Howard Hughes Medical Institute and the Departments of Medicine, Biochemistry, and Molecular Biophysics, Washington University School of Medicine, St Louis, MO; and the Department of Hematology, Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen C. J.","family":"Eikenboom","sequence":"additional","affiliation":[{"name":"From the Howard Hughes Medical Institute and the Departments of Medicine, Biochemistry, and Molecular Biophysics, Washington University School of Medicine, St Louis, MO; and the Department of Hematology, Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Dong","sequence":"additional","affiliation":[{"name":"From the Howard Hughes Medical Institute and the Departments of Medicine, Biochemistry, and Molecular Biophysics, Washington University School of Medicine, St Louis, MO; and the Department of Hematology, Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Evan","family":"Sadler","sequence":"additional","affiliation":[{"name":"From the Howard Hughes Medical Institute and the Departments of Medicine, Biochemistry, and Molecular Biophysics, Washington University School of Medicine, St Louis, MO; and the Department of Hematology, Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021217132542200_B1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0609.1992.tb00584.x","article-title":"von Willebrand's disease.","volume":"48","author":"Holmberg","year":"1992","journal-title":"Eur J Haematol."},{"key":"2020021217132542200_B2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor.","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem."},{"key":"2020021217132542200_B3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor.","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol."},{"key":"2020021217132542200_B4","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations.","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0038-1651576","article-title":"von Willebrand disease: a database of point mutations, insertions, and deletions.","volume":"69","author":"Ginsburg","year":"1993","journal-title":"Thromb Haemost."},{"key":"2020021217132542200_B6","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood."},{"key":"2020021217132542200_B7","first-page":"373a","article-title":"Mutations causing dominant type 1 von Willebrand disease with high penetrance.","volume":"94(suppl 1)","author":"Bodo\u0301","year":"1999","journal-title":"Blood."},{"key":"2020021217132542200_B8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-0037-1613769","article-title":"Von Willebrand Disease type 2M \u201cVicenza\u201d in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families.","volume":"83","author":"Schneppenheim","year":"2000","journal-title":"Thromb Haemost."},{"key":"2020021217132542200_B9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"von Willebrand disease \u201cVicenza\u201d with larger-than-normal (supranormal) von Willebrand factor multimers.","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood."},{"key":"2020021217132542200_B10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(91)90648-I","article-title":"Induction of specific storage organelles by von Willebrand factor propolypeptide.","volume":"64","author":"Wagner","year":"1991","journal-title":"Cell."},{"key":"2020021217132542200_B11","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1016\/S0021-9258(17)37439-2","article-title":"Disulfide bonds required to assemble functional von Willebrand factor multimers.","volume":"269","author":"Dong","year":"1994","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MCB.7.1.379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.","volume":"7","author":"Dubridge","year":"1987","journal-title":"Mol Cell Biol."},{"key":"2020021217132542200_B13","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/MCB.7.8.2745","article-title":"High-efficiency transformation of mammalian cells by plasmid DNA.","volume":"7","author":"Chen","year":"1987","journal-title":"Mol Cell Biol."},{"key":"2020021217132542200_B14","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.270.22.13406","article-title":"Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib: charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.","volume":"270","author":"Matsushita","year":"1995","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0049-3848(90)90181-B","article-title":"Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel.","volume":"60","author":"Raines","year":"1990","journal-title":"Thromb Res."},{"key":"2020021217132542200_B16","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.88.14.6377","article-title":"Expression of von Willebrand factor \u201cNormandy\u201d: an autosomal mutation that mimics hemophilia A.","volume":"88","author":"Tuley","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217132542200_B17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature."},{"key":"2020021217132542200_B18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V83.6.1551.1551","article-title":"Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations.","volume":"83","author":"Lyons","year":"1994","journal-title":"Blood."},{"key":"2020021217132542200_B19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1055\/s-0038-1642524","article-title":"Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.","volume":"71","author":"Pietu","year":"1994","journal-title":"Thromb Haemost."},{"key":"2020021217132542200_B20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1432-1033.1991.tb15826.x","article-title":"Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin.","volume":"196","author":"Sixma","year":"1991","journal-title":"Eur J Biochem."},{"key":"2020021217132542200_B21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1650400","article-title":"A3 domain is essential for interaction of von Willebrand factor with collagen type III.","volume":"75","author":"Lankhof","year":"1996","journal-title":"Thromb Haemost."},{"key":"2020021217132542200_B22","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/bi00399a013","article-title":"Identification of disulfide-bridged substructures within human von Willebrand factor.","volume":"26","author":"Marti","year":"1987","journal-title":"Biochemistry."},{"key":"2020021217132542200_B23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0021-9258(18)54131-4","article-title":"Interrelations between assembly and secretion of recombinant human acetylcholinesterase.","volume":"268","author":"Kerem","year":"1993","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B24","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1002\/j.1460-2075.1993.tb06164.x","article-title":"Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation.","volume":"12","author":"Fra","year":"1993","journal-title":"EMBO J."},{"key":"2020021217132542200_B25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.cellbio.14.1.19","article-title":"Ubiquitin and the control of protein fate in the secretory and endocytic pathways.","volume":"14","author":"Bonifacino","year":"1998","journal-title":"Annu Rev Cell Dev Biol."},{"key":"2020021217132542200_B26","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.273.15.8545","article-title":"Lactacystin, proteasome function, and cell fate.","volume":"273","author":"Fenteany","year":"1998","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B27","doi-asserted-by":"crossref","first-page":"25585","DOI":"10.1074\/jbc.M002654200","article-title":"Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor.","volume":"275","author":"Katsumi","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease.","volume":"69","author":"Gill","year":"1987","journal-title":"Blood."},{"key":"2020021217132542200_B29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.126.1.41","article-title":"Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus.","volume":"126","author":"Hammond","year":"1994","journal-title":"J Cell Biol."},{"key":"2020021217132542200_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.140.1.1","article-title":"Retrograde transport of Golgi-localized proteins to the ER.","volume":"140","author":"Cole","year":"1998","journal-title":"J Cell Biol."},{"key":"2020021217132542200_B31","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/j.1460-2075.1992.tb05223.x","article-title":"Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum.","volume":"11","author":"Braakman","year":"1992","journal-title":"EMBO J."},{"key":"2020021217132542200_B32","doi-asserted-by":"crossref","first-page":"20598","DOI":"10.1016\/S0021-9258(20)80767-4","article-title":"The secretory pathway is normal in dithiothreitol-treated cells, but disulfide-bonded proteins are reduced and reversibly retained in the endoplasmic reticulum.","volume":"268","author":"Lodish","year":"1993","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/blood.V81.3.683.683","article-title":"Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.","volume":"81","author":"Lentz","year":"1993","journal-title":"Blood."},{"key":"2020021217132542200_B34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.286.5446.1882","article-title":"Setting the standards: quality control in the secretory pathway.","volume":"286","author":"Ellgaard","year":"1999","journal-title":"Science."},{"key":"2020021217132542200_B35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/74035","article-title":"Recognition of local glycoprotein misfolding by the ER folding sensor UDP-glucose:glycoprotein glucosyltransferase.","volume":"7","author":"Ritter","year":"2000","journal-title":"Nat Struct Biol."},{"key":"2020021217132542200_B36","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI112129","article-title":"Substructure of human von Willebrand factor.","volume":"76","author":"Fowler","year":"1985","journal-title":"J Clin Invest."},{"key":"2020021217132542200_B37","doi-asserted-by":"crossref","first-page":"15679","DOI":"10.1016\/S0021-9258(18)66771-7","article-title":"Substructure of human von Willebrand factor: proteolysis by V8 and characterization of two functional domains.","volume":"261","author":"Fretto","year":"1986","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood.V95.4.1336.004k16_1336_1341","article-title":"Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion.","volume":"95","author":"Duga","year":"2000","journal-title":"Blood."},{"key":"2020021217132542200_B39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9440(10)64530-0","article-title":"Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a \u03b3284 Gly\u2192Arg mutation.","volume":"157","author":"Brennan","year":"2000","journal-title":"Am J Pathol."},{"key":"2020021217132542200_B40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00496800","article-title":"Hereditary hypofibrinogenemia with fibrinogen storage in the liver.","volume":"141","author":"Wehinger","year":"1983","journal-title":"Eur J Pediatr."},{"key":"2020021217132542200_B41","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1074\/jbc.270.15.8642","article-title":"Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro \u03b1 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.","volume":"270","author":"Lamande","year":"1995","journal-title":"J Biol Chem."},{"key":"2020021217132542200_B42","doi-asserted-by":"crossref","first-page":"22522","DOI":"10.1016\/S0021-9258(18)41703-6","article-title":"An amino acid substitution (Gly853\u2192Glu) in the collagen \u03b1 1(II) chain produces hypochondrogenesis.","volume":"267","author":"Bogaert","year":"1992","journal-title":"J Biol Chem."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/10\/2973\/1678417\/h8220102973.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/10\/2973\/1678417\/h8220102973.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:30:16Z","timestamp":1622021416000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/10\/2973\/53013\/Type-1-von-Willebrand-disease-mutation-Cys1149Arg"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,15]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.10.2973","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,15]]}}}